Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the site version updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:25:17.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    UI enhancements include a Show glossary option and color-coded highlights for additions (green) and deletions (red) in the record history. The revision banner now displays Revision: v3.4.0.
    Difference
    1%
    Check dated 2026-01-28T04:25:42.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (Revision: v3.3.4) replacing the prior version (v3.3.3) with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new revision entry: Revision: v3.3.3 to the Record History; removed the HHS Vulnerability Disclosure and the older Revision: v3.3.2 entry.
    Difference
    0.2%
    Check dated 2025-12-23T17:20:50.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added and v3.2.0 was removed in the record history. This appears to be an administrative version update rather than content changes.
    Difference
    0.1%
    Check dated 2025-11-24T21:33:08.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Notice banner about government funding and operating status was removed from the page. The page now presents the study history without this banner.
    Difference
    0.8%
    Check dated 2025-11-17T19:22:46.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.